Clinical Outcomes After Anterior Cruciate Ligament Injury: Panther Symposium ACL Injury Clinical Outcomes Consensus Group. Issue 7 (16th July 2020)

• Record Type: Journal Article
• Authors: Svantesson, Eleonor; Hamrin Senorski, Eric; Webster, Kate E.; Karlsson, Jón; Diermeier, Theresa; Rothrauff, Benjamin B.; Meredith, Sean J.; Rauer, Thomas; Irrgang, James J.; Spindler, Kurt P.; Ma, C. Benjamin; Musahl, Volker; the Panther Symposium ACL Injury Clinical Outcomes Consensus Group, ; Fu, Freddie H.; Ayeni, Olufemi R.; Della Villa, Francesco; Della Villa, Stefano; Dye, Scott; Ferretti, Mario; Getgood, Alan; Järvelä, Timo; Kaeding, Christopher C.; Kuroda, Ryosuke; Lesniak, Bryson; Marx, Robert G.; Maletis, Gregory B.; Pinczewski, Leo; Ranawat, Anil; Reider, Bruce; Seil, Romain; van Eck, Carola; Wolf, Brian R.; Yung, Patrick; Zaffagnini, Stefano; Hao Zheng, Ming;
• Is Part Of: Orthopaedic journal of sports medicine. Volume 8:Issue 7(2020)
• Publication Date: 2020-07-16
• Subjects: reconstruction -- patient-reported outcome -- laxity -- osteoarthritis -- consensus statement; Sports medicine -- Periodicals; Orthopedics -- Periodicals; Arthroscopy -- Periodicals; Arthroplasty -- Periodicals; Knee -- Surgery -- Periodicals; 616.7
• DOI: 10.1177/2325967120934751
• Languages: English
• ISSNs: 2325-9671

Abstract

A stringent outcome assessment is a key aspect of establishing evidence-based clinical guidelines for anterior cruciate ligament (ACL) injury treatment. To establish a standardized assessment of clinical outcome after ACL treatment, a consensus meeting including a multidisciplinary group of ACL experts was held at the ACL Consensus Meeting Panther Symposium, Pittsburgh, Pennsylvania, USA, in June 2019. The aim was to establish a consensus on what data should be reported when conducting an ACL outcome study, what specific outcome measurements should be used, and at what follow-up time those outcomes should be assessed. The group reached consensus on 9 statements by using a modified Delphi method. In general, outcomes after ACL treatment can be divided into 4 robust categories: early adverse events, patient-reported outcomes (PROs), ACL graft failure/recurrent ligament disruption, and clinical measures of knee function and structure. A comprehensive assessment after ACL treatment should aim to provide a complete overview of the treatment result, optimally including the various aspects of outcome categories. For most research questions, a minimum follow-up of 2 years with an optimal follow-up rate of 80% is necessary to achieve a comprehensive assessment. This should include clinical examination, any sustained reinjuries, validated knee-specific PROs, and health-related quality of life questionnaires. In the midterm to long-term follow-up, the presence of osteoarthritis should be evaluated. This consensus paper provides practical guidelines for how the aforementioned entities of outcomes should be reported and suggests the preferred tools for a reliable and valid assessment of outcome after ACL treatment.